Hadassah

Hadassah Opens Clinic to Support Women Through Life-cycle Challenges

Thursday, Jan 8 2015

To support women facing challenges related to their reproductive cycles, the Hadassah Medical Center is opening a new clinic.

Whether it is the need for hormonal treatments to achieve a pregnancy, help with postpartum depression, or support through the transition to menopause, the clinic staff will work in conjunction with their colleagues in the Women’s Health Center to offer comprehensive multidisciplinary support.

Recognizing that upheaval at all stages of the reproductive cycle requires experts who are cognizant of the biological, social, and emotional changes a woman is going through, the clinic specialists aim to head off syndromes that can have consequences for women years later.

Senior Psychiatrist Prof. Ronen Segman, whose research has documented the molecular aspects of post-natal depression, explains: "The hormonal overload--the same feeling that may cause moodiness at certain times of the month--is involved in post-natal depression, and it often goes unrecognized in a community clinic, although it is the most common complication of modern childbirth.”

She adds: “Both women and their families, particularly children, will suffer if the mother’s emotional issues go untreated.”

Comments

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More